过敏性疾病与精神心理因素的相互关系

doi:10.6040/j.issn.1673-3770.0.2022.391

摘要/Abstract

摘要： 过敏性疾病主要是由免疫球蛋白E介导的一大类疾病,影响了全球约20%的人口。与过敏性疾病患病率增加相平行的是各种社会心理压力的增加。过敏性疾病的安慰剂效应和反安慰剂效应均提示精神心理因素与过敏性疾病密切相关。心理干预和治疗不可忽略,临床医师必须遵循生物-心理-社会的医学新模式,及时打破精神心理与过敏性疾病的恶性循环链,提高过敏性疾病的治疗有效率。论文综述过敏性疾病与精神心理问题的相互关系,以期为临床实践提供指导。

关键词: 过敏性疾病, 精神心理因素, 安慰剂效应, 反安慰剂效应

Abstract: Allergic diseases are a major class of diseases mediated by immunoglobulin E, affecting about 20% of the global population. Parallel to the increase in the prevalence of allergic diseases is the increase in various social and psychological pressures. The placebo and nocebo effects of allergic diseases suggest that psychosocial factors are closely related to allergic diseases. Psychological intervention and treatment cannot be ignored. Clinicians must follow the new medical model of biology psychology society, break the vicious cycle of mental psychology and allergic diseases in a timely manner, and improve the treatment efficiency of allergic diseases.The paper reviews the interrelationships between allergic diseases and psychological problems. This article reviews the relationship between allergic diseases and psychosocial problems in order to provide guidance for clinical practice.

Key words: Allergic disease, Psychological factors, Placebo effect, Nocebo effect

中图分类号:

R392.8

樊长娥,张俊晶,王洪田,马婷婷,王学艳. 过敏性疾病与精神心理因素的相互关系[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 101-105.

FAN Chang'e, ZHANG Junjing, WANG Hongtian, MA Tingting, WANG Xueyan. Relationship between allergic diseases and mental-psychological factors[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 101-105.

参考文献

[1] Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy[J]. Expert Rev Pharmacoecon Outcomes Res, 2020, 20(5): 437-453. doi:10.1080/14737167.2020.1819793
[2] 廖小刚, 朱爱勇, 王欣国, 等. 中国成人哮喘患病率的Meta分析[J]. 中国循证医学杂志, 2020, 20(10): 1164-1172
[3] Lin JT, Wang WY, Chen P, et al. Prevalence and risk factors of asthma in mainland China: the CARE study[J]. Respir Med, 2018, 137: 48-54. doi:10.1016/j.rmed.2018.02.010
[4] Jarosz M, Syed S, Bachut M, et al. Emotional distress and quality of life in allergic diseases[J]. Wiad Lek, 2020, 73(2):370-373
[5] 锡琳, 曹飞飞, 熊巍, 等. 变应性鼻炎患者焦虑状态分析[J]. 中华耳鼻咽喉头颈外科杂志, 2014, 49(10): 828-831. doi: 10.3760/cma.j.issn.1673-0860.2014.10.008
[6] Tas HI, Caglar O. The role of anxious temperament in patients with allergic rhinitis[J]. Saudi Med J, 2019, 40(1): 45-51. doi:10.15537/smj.2019.1.23754
[7] Huang HY, Wang YC, Zhang LZ, et al. Psychological disorders of patients with allergic rhinitis in Chengdu, China: exploratory research[J]. JMIR Form Res, 2022, 6(11): e37101. doi:10.2196/37101
[8] Griffiths D, Giancola LM, Welsh K, et al. Asthma control and psychological health in pediatric severe asthma[J]. Pediatr Pulmonol, 2021, 56(1): 42-48. doi:10.1002/ppul.25120
[9] Bedolla-Barajas M, Morales-Romero J, Fonseca-López JC, et al. Anxiety and depression in adult patients with asthma: the role of asthma control, obesity and allergic sensitization[J]. J Asthma, 2021, 58(8): 1058-1066. doi:10.1080/02770903.2020.1759087
[10] Zhang HH, Xia Y, Zhang XS, et al. Bi-directional associations between depressive symptoms and asthma in middle-aged and elderly adults in China[J]. J Affect Disord, 2022, 314: 117-123. doi:10.1016/j.jad.2022.07.013
[11] Tat TS. Higher levels of depression and anxiety in patients with chronic urticaria[J]. Med Sci Monit, 2019, 25: 115-120. doi:10.12659/MSM.912362
[12] Alan S, Canan F, Karaka??塂 AA, et al. Temperament and character profiles of patients with chronic idiopathic urticaria[J]. Postepy Dermatol Alergol, 2015, 32(3): 167-172. doi:10.5114/pdia.2015.48063
[13] Silverberg JI, Gelfand JM, Margolis DJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults[J]. Br J Dermatol, 2019, 181(3): 554-565. doi: 10.1111/bjd.17683
[14] 魏芬, 江建, 陈宏翔. 心身性皮肤病概论[J]. 皮肤科学通报, 2021, 38(2): 102-107
[15] 杨家慧, 陈宏翔, 喻楠. 心身性皮肤病特点与类型的研究进展[J]. 皮肤科学通报, 2021, 38(2): 157-161
[16] 李萌, 周昕欣. 从“情志怫郁”论慢性荨麻疹的病因病机[J]. 陕西中医药大学学报, 2023, 46(3):55-58. doi:10.13424/j.cnki.jsctcm.2023.03.011
[17] 吴志洪, 张衍, 黄琴, 等. 中医皮肤病学情志致病的教学思路[J]. 中国中医药现代远程教育, 2022, 20(13): 3-5
[18] Jiang X, Shen C, Dai Y, et al. Early food allergy and respiratory allergy symptoms and attention-deficit/hyperactivity disorder in Chinese children: A cross-sectional study[J]. Pediatr Allergy Immunol, 2018, 29(4): 402-409. doi: 10.1111/pai.12888
[19] Lin YT, Chen YC, Gau SS, et al. Associations between allergic diseases and attention deficit hyperactivity/oppositional defiant disorders in children[J]. Pediatr Res, 2016, 80(4): 480-485. doi:10.1038/pr.2016.111
[20] Yang CF, Yang CC, Wang IJ. Association between allergic diseases, allergic sensitization and attention-deficit/hyperactivity disorder in children: a large-scale, population-based study[J]. J Chin Med Assoc, 2018, 81(3): 277-283. doi:10.1016/j.jcma.2017.07.016
[21] del Cuvillo A, Sastre J, Bartra J, et al. Placebo effect in clinical trials involving patients with allergic rhinitis[J]. J Investig Allergol Clin Immunol, 2011, 21(Suppl 3): 40-45
[22] Pfaar O, Agache I, Bergmann KC, et al. Placebo effects in allergen immunotherapy-an EAACI task force position paper[J]. Allergy, 2021, 76(3): 629-647. doi:10.1111/all.14331
[23] Frew AJ, Pfaar O. Placebo effects in allergen immunotherapy: an experts' opinion[J]. Allergo J Int, 2018, 27(6): 162-166. doi:10.1007/s40629-018-0065-z
[24] Pfaar O, Agache I, Bergmann KC, et al. Placebo effects in allergen immunotherapy-An EAACI Task Force Position Paper[J]. Allergy, 2021, 76(3): 629-647. doi: 10.1111/all.14331
[25] Schaefer M, Enck P. Effects of a probiotic treatment(Enterococcus faecalis)and open-label placebo on symptoms of allergic rhinitis: study protocol for a randomised controlled trial[J]. BMJ Open, 2019, 9(10): e031339. doi:10.1136/bmjopen-2019-031339
[26] 王洪田, 王学艳. 变应性鼻炎防治中应重视环境控制和加强健康教育[J]. 中华预防医学杂志, 2023, 57(3): 318-326. doi: 10.3760/cma.j.cn112150-20221103-01058
[27] Bartels DJ, van Laarhoven AI, Haverkamp EA, et al. Role of conditioning and verbal suggestion in placebo and nocebo effects on itch[J]. PLoS One. 2014, 9(3): e91727. doi: 10.1371/journal.pone.0091727
[28] Kong J, Gollub RL, Polich G, et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect[J]. J Neurosci, 2008, 28(49): 13354-13362. doi:10.1523/JNEUROSCI.2944-08.2008
[29] Tracey I. Getting the pain You expect: mechanisms of placebo, nocebo and reappraisal effects in humans[J]. Nat Med, 2010, 16(11): 1277-1283. doi:10.1038/nm.2229
[30] 独宁鸽,化振,燕真峰. 支气管哮喘患者的应付方式及人格特征的研究[J]. 国际呼吸杂志, 2013, 33(5): 334-336
[31] Wang XY, Ma TT, Wang XY, et al. Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of Northern China[J]. Allergy, 2018, 73(6): 1232-1243. doi:10.1111/all.13388
[32] Wang LX, Yang ZC, Kang ZP, et al. Improvement in psychological condition of patients with persistent moderate-severe allergic rhinitis by drug therapy combined with psychological intervention[J]. Ear Nose Throat J, 2021, 100(5): 684-690. doi: 10.1177/0145561320902859
[33] 王学艳. 扎根基层建设健康中国推动学科高质量发展[J]. 中华临床免疫和变态反应杂志, 2022, 16(4): 339-342
[34] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年,修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 106-129. doi: 10.3760/cma.j.cn115330-20211228-00828
[35] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组、小儿学组. 儿童变应性鼻炎诊断和治疗指南(2022年, 修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(4): 392-404. doi: 10.3760/cma.j.cn115330-20220303-00092
[36] LAI Rong, LIANG Dan, YIN Jie, et al. Mental status Analysis and structured psychological intervention of allergic patient[J]. Sichuan Medical Journal, 2010, 31(9): 1288-1289

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed